Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

Full description

Saved in:
Bibliographic Details
Main Author: Petrick, Joy Kristin
Contributors: Klebe, Gerhard (Prof. Dr.) (Thesis advisor)
Format: Dissertation
Published: Philipps-Universität Marburg 2019
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!


PDF Full Text

Holdings details from
Call Number: urn:nbn:de:hebis:04-z2019-05018
Downloads: 148 (2021), 49 (2020)
Publication Date: 2020-05-25
License: According to UrhG § 31 (2), the author has granted the University Library Marburg the right of use for electronic publication on the Internet and for archiving on its archive server. He has declared that with the granting of the right of use according to UrhG § 31 (3) no exclusive rights of third parties are violated. All other rights for the exploitation of the publication remain with the author.
Access URL: